Indonesia's Food and Drug Administration (BPOM) has expressed concern about the increasing circulation of 'Obat Setelan' (customized drugs). While these drugs are claimed to be effective for treating specific diseases, BPOM warned that their safety and efficacy have not been verified. 'Obat Setelan' are pills or capsules packaged in plastic, widely sold from online shopping platforms to small retail stores. BPOM pointed out that the drug composition is unclear, product information is lacking, and there is potential for inclusion of powerful drugs that require prescriptions. Particular concern was raised about antibiotic misuse, which can lead to bacterial antibiotic resistance. BPOM advised the public to refrain from purchasing and using 'Obat Setelan' and to consult with doctors or pharmacists if health problems arise.
